Weekly Wisdom – August 2, 2023

By Hightower Great Lakes on August 2, 2023

Top-Down vs. Bottom-Up Approach to China

China has long been one of the driving forces in the global economy. While China-U.S. relations have steadily deteriorated since the Trump tariffs in 2018, China continues to dominate global trade, increasing its share of global good exports to 14.4% in 2022 from 13% in the prior year.[1]

China has long benefited from strong consumer spending overseas. However, Covid lockdowns, rising global interest rates, geopolitical tensions and reshoring present challenges. While hope abounded in early 2023 as China removed pandemic-era restrictions, that hope has plateaued as export numbers and global discretionary spending on goods has waned in the face of a possible recession.

As economic data steadily improves in the U.S., mixed economic data out of China tells a different story. The benefit of corporate earnings season is that we get to hear directly from the companies that operate on the ground in places like China. As earnings season kicks into high gear, we see it prudent to recap what has been reported by a broad array of companies, offering a bottom-up analysis on China. 

Chart 1: China Exports, y/y Growth[2]

Macro Data Mixed

China’s economic data is a mixed bag. Caixin Manufacturing PMI, which is a survey that measures China’s manufacturing activity, recently dipped into contractionary territory (49.2) after two consecutive months of expansion. However, Caixin Services PMI, which measures China’s services activity, remains in expansionary territory (53.9), albeit at the lowest point since January.

There are underlying factors limiting China’s ability to return to pre-pandemic levels. First, leading-edge semiconductor export restrictions on U.S. companies to China enacted last fall in the name of national security have curtailed China’s ability to reinvigorate its economy.

Further, at the onset of the pandemic, U.S. and Chinese governments restricted flights to prevent the spread of the disease. There were about 350 flights a week between the two countries prior to the pandemic; currently, that number sits at 24. The lacking ability to travel has put a ceiling on travel expenditures.

Consumer Facing Commentary Signals Continued Growth

Many tourism-related companies, including airlines, hotels and leisure, have reported a strong rebound in consumption. Most recently, Marriott International (MAR) reported that average daily room rate increased 34% y/y, along with occupancy up 28% y/y, which drove the company to raise its full-year earnings outlook.[3]

On Boeing’s (BA) recent earnings call, management noted that “the return to service in China is now largely complete.” Driving the China recovery is passenger traffic at 87% of pre-pandemic levels and domestic travel up 300% y/y, indicating Chinese consumers are looking to get back out and spend.

United Airlines (UAL) had similar positive commentary on China, as it reported international margins well-above 2019 levels, with a 27% increase for international capacity.[4] United anticipates expanding its international offerings later this year after finalizing the largest widebody aircraft order in history with Boeing.

While it is evident that Chinese consumers are back to spending domestically, Chinese companies are looking to regain their footing in international markets as well. This was noted by Meta (META) during its recent second quarter earnings call. Advertising revenue growth was bolstered by the online commerce vertical, which was driven by strong spend among advertisers in China looking to reach customers in other markets.[5]

Meta credits easing regulations on the Chinese gaming industry in tandem with improved artificial intelligence advertising targeting. Shown in the chart below, Macau, China’s version of Las Vegas, has seen a recent resurgence in revenues.

Chart 2: Macau Gaming Revenue[6]

Evidently, China’s consumer-facing industries are gaining momentum. However, industrial, energy, materials and even semiconductor companies will offer a lens into the plumbing of the Chinese economy.

It Works! Materials, Energy and Semiconductor Strength

Chemical production, more specifically plastic, is a good place to start. China is the world’s largest consumer of plastics including high-density polyethylene (HDPE).[7] Dow Chemical (DOW) is a major manufacturer of HDPE and other petrochemical products. Key end markets for Dow’s chemical products include construction, industrial, mobility and personal care products.[8]

While yet to fully materialize, Dow noted its ability to “move good volume into China.”[9] Management is optimistic their efforts will result in further China growth, and acknowledged that despite lower than pre-pandemic levels, GDP growth in the 4.5-5% range is still very good for the second largest economy in the world.[10]

Exxon Mobile (XOM), like Dow, has business in petrochemicals, and furthered the positive commentary in its recent earnings call where management noted a recent increase in chemicals demand.[11]

Exxon’s second quarter chemical sales increased sequentially and said that the demand of out China looks reasonable, however, it may take a few months for demand to catch up with current supply.

China is the world’s second largest consumer of crude oil.[12] Goldman Sachs recently downgraded China’s 2023 crude oil demand by 125kb/d but noted a recovery in jet fuel demand provides potential upside for the projection.[13] Previously mentioned commentary out of both Boeing and United Airlines provides evidence that jet fuel demand in China is set to accelerate.

China is the world’s largest consumer of refined copper, a key input in electrification, including the quickly growing electric vehicles segment.[14] Freeport-McMoRan (FCX) is a major player in copper mining. It weighed in on China during its most recent earnings call, confirming demand for copper in China is strong and that the country remains the world’s largest copper consumer.[15]

While acknowledging the slower recovery from the era of Covid lockdowns, copper consumption continues to grow, supported by investments in electrical grid and EV production.[16]

Despite the slower than expected recovery, the electrification theme remains a bright spot. China is one of the largest consumers of commodities given its manufacturing capacity and massive population. With a large population, healthcare providers have large interests in the nation. 

China’s medical device market is valued at $42.6 billion or 8.3%, putting it in the top 10 markets globally.[17] GE Healthcare (GEHC) is a major producer of medical devices that are consumed by China.[18] GE Healthcare was able to grow sales within all regions including China, where revenue grew double digits.

The company predicts that this growth should continue into the third quarter and is increasing its China localization.[19] The medical device manufacturer’s commentary is in line with the commodity driven companies previously mentioned. Key components in medical as well as almost every other device are semiconductors.

As previously noted, the United States Bureau of Industry and Security (BIS) announced export controls on high-end semiconductor devices to limit China’s potential military and supercomputer capabilities.

Despite these export controls, Lam Research (LRCX) noted in its recent fiscal fourth quarter earnings call that demand from Chinese customers has shifted toward trailing edge chips where they are permitted to invest.[20]

These chips are used in typical household products and handheld devices. The increased wafer fabrication equipment (WFE) expenditure out of China allowed Lam to increase its expectation for global WFE expenditures. Investors see the expenditures out of China as a bridge to a broader increase in WFE that is expected in the coming months.

Primed for a Recovery

The pandemic, rapidly changing technology and a power struggle with the U.S. have all worked against China in recent years. However, American management teams’ willingness to work with their Chinese counterparts is displayed in the earnings call commentary.

The broad-based commentary from the earnings calls gives the impression that China is a far cry from submitting and will continually find new avenues for growth. For that reason, we remain confident in companies with China exposure and continue to keep a close eye on all data that is released, for we will be positioned to capitalize on the opportunity when it presents itself.  

Click here to read last week’s Weekly Wisdom (7/27).

Disclosures

Investment Solutions is a group comprised of investment professionals registered with Hightower Advisors, LLC, an SEC registered investment adviser. Some investment professionals may also be registered with Hightower Securities, LLC, member FINRA and SIPC. Advisory services are offered through Hightower Advisors, LLC. Securities are offered through Hightower Securities, LLC.

This is not an offer to buy or sell securities. No investment process is free of risk, and there is no guarantee that the investment process or the investment opportunities referenced herein will be profitable. Past performance is neither indicative nor a guarantee of future results. The investment opportunities referenced herein may not be suitable for all investors.

All data or other information referenced herein is from sources believed to be reliable. Any opinions, news, research, analyses, prices, or other data or information contained in this presentation is provided as general market commentary and does not constitute investment advice. Investment Solutions and Hightower Advisors, LLC or any of its affiliates make no representations or warranties express or implied as to the accuracy or completeness of the information or for statements or errors or omissions, or results obtained from the use of this information. Investment Solutions and Hightower Advisors, LLC assume no liability for any action made or taken in reliance on or relating in any way to this information. The information is provided as of the date referenced in the document. Such data and other information are subject to change without notice.

This document was created for informational purposes only; the opinions expressed herein are solely those of the author(s) and do not represent those of Hightower Advisors, LLC, or any of its affiliates.

---

[1] Source: WSJ.com. As of July 13, 2023.

[2] Source: FactSet. As of August 1, 2023.

[3] Source: Investing.com. As of August 1, 2023.

[4] Source: Bizjournals.com. As of July 20, 2023.

[5] Source: CNN. As of July 26, 2023.

[6] Source: Bloomberg. As of August 1, 2023.

[7] Source: GlobalData. As of April 21, 2023.

[8] Source: Dow Inc. As of July 20, 2023.

[9] Source: Barrons. As of August 1, 2023.

[10] Source: The Motley Fool. As of July 25, 2023.

[11] Source: Barron’s. As of July 28, 2023.

[12] Source: Wise Voter. As of July 19, 2023.

[13] Source: Goldman Sachs. As of July 30, 2023.

[14] Source: Yahoo. As of November 20, 2022.

[15] Source: Statista. As of March 6, 2023.

[16] Source: Seeking Alpha. As of July 20, 2023.

[17] Source: Medical Device Network. As of July 5, 2022.

[18] Source: Market Watch. As of July 25, 2023.

[19] Source: Seeking Alpha. As of July 25, 2023.

[20] Source: Barron’s. As of July 24, 2023.